Clinical Trial Update: Calfactant for Direct Acute Respiratory Distress Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial of calfactant for direct acute respiratory distress syndrome was terminated; no trial results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Calfactant (calfactant)

Snippet

Sponsor: Pneuma Pharmaceuticals Incorporated | Conditions: Respiratory Distress Syndrome, Adult | Phase 3 | Status: TERMINATED